Learning outcomes
By the end of this lesson you should be able to: contrast MHC class I and class II antigen presentation and say which CD4 or CD8 subset each addresses; explain the two-signal model of T-cell activation and what happens when the second signal is absent; describe T-cell development and the selection that produces self-tolerance; describe the four CD4 helper subsets and one clinical setting in which each dominates; describe cytotoxic T-cell killing and the apoptosis it induces; explain delayed-type hypersensitivity and the granuloma; and interpret the CD4 count in HIV and the risk it predicts.
Prerequisites
Lessons 5 and 6 — innate immunity and humoral adaptive immunity. Dendritic cells and the T follicular helper cells from those two lessons supply the context, and the vocabulary of antigen presentation is introduced here.
The big idea
An antibody can bind a virus in the bloodstream brilliantly, but it cannot enter a cell to reach a virus that has already infected one. Cell-mediated immunity solves this by looking at the surface of every cell in the body: proteins synthesised inside a cell are chopped up, loaded onto MHC molecules and displayed on the membrane, and a T cell inspects the display. A bacterium hiding in a macrophage is visible too — the macrophage itself has swallowed it and is presenting its peptides.
This explains the immunological split you meet in the clinical wards. A patient with agammaglobulinaemia cannot neutralise organisms in the extracellular fluid and gets bacterial sinusitis and bronchitis — viral infections are handled normally, because the T cells are intact. A patient with AIDS cannot clear intracellular pathogens, so they get Pneumocystis pneumonia, cryptococcal meningitis, cytomegalovirus retinitis, disseminated mycobacteria — the extracellular bacterial world is largely intact. The pattern of infection is a direct readout of which arm is missing.
Antigen presentation: the two MHC pathways
| Feature | MHC class I | MHC class II |
|---|---|---|
| Expressed on | All nucleated cells | Dendritic cells, macrophages, B cells, and thymic epithelium; induced on others by interferon-gamma |
| Source of peptide | Proteins synthesised inside the cell — endogenous, including viral and tumour antigens | Proteins phagocytosed from outside — exogenous, including bacteria that have been engulfed |
| Peptide length and binding | Peptides of about 8–10 amino acids, binding the closed groove | Peptides of about 13–25 amino acids, in an open groove |
| Which T cell reads it | CD8 cytotoxic T cells, because CD8 binds the alpha-3 domain of class I | CD4 helper T cells, because CD4 binds a conserved region on class II |
| Function | Kill the infected or malignant cell | Direct the immune response — activating macrophages, helping B cells, recruiting cells |
NoteCross-presentation is the exception that makes it work: dendritic cells can also load material they have engulfed extracellularly onto MHC class I, so a virus produced elsewhere can still reach CD8 T cells. This is essential for defence against viruses that do not infect dendritic cells themselves, and it is the basis on which cancer vaccines are designed.
The contrast with immunoglobulin is worth stating. An antibody sees an antigen in three dimensions, in any conformation. A T cell sees only a peptide, in a groove, of a fixed length, presented on a defined molecule — which is why a virus can escape both arms by mutating a peptide anchor residue, and why HLA type determines which epitopes a person can see.
T-cell development: positive and negative selection
T-cell precursors mature in the thymus. The beta locus rearranges first, then the alpha; if a cell survives, it expresses both CD4 and CD8 before choosing a lineage. Selection happens in two directions. In positive selection, thymic epithelial cells display self-MHC molecules and cells that cannot engage any of them die of neglect — so the mature repertoire is restricted to cells that can read self-MHC. In negative selection, medullary epithelial cells and dendritic cells display self-peptides, and cells that recognise them too strongly are deleted — the origin of central tolerance.
NoteFailure of positive selection deletes nearly the whole repertoire, which is why DiGeorge syndrome — 22q11.2 deletion, thymic hypoplasia and hypoparathyroidism from the same branchial arch field — produces recurrent infections and infant hypocalcaemic tetany together. Failure of negative selection is the origin of autoimmune polyendocrine syndrome type 1, where the AIRE transcription factor that lets thymic cells display tissue-specific proteins is defective.
Activation: two signals, and the tolerance that follows without one
| Signal | What delivers it | What happens if it is missing |
|---|---|---|
| Signal 1 | The T-cell receptor engaging peptide–MHC, with CD4 or CD8 as co-receptor | The cell does nothing — it simply cannot respond |
| Signal 2 | B7 (CD80 and CD86) on the professional antigen-presenting cell engaging CD28 on the T cell | The cell becomes anergic or tolerant rather than activated |
| Cytokine signal 3 | Interleukin-2 in particular, autocrine and paracrine | Activation is weaker and the T helper subset differentiation is altered |
NoteThe two-signal model is why resting tissues do not turn every minor self-antigen into autoimmunity: they present peptide in MHC class II but usually without B7, so a self-reactive T cell receives signal 1 and becomes anergic. This is also why Abatacept, a fusion protein that blocks B7-CD28, is a therapy for rheumatoid arthritis — it withholds the second signal.
The CD4 helper subsets
Once activated, a naive CD4 cell differentiates into a lineage directed by the cytokines present at the moment of activation. The four classic subsets each recruit a different cell to the response, and the pattern of infection in a patient on a monoclonal antibody that blocks one of them follows directly.
| Subset | Master transcription factor | Signature cytokine | What it recruits | Disease where it dominates |
|---|---|---|---|---|
| Th1 | T-bet | Interferon-gamma | Macrophages — the classical macrophage activation pathway | Tuberculosis, tuberculoid leprosy, granulomatous inflammation |
| Th2 | GATA-3 | Interleukin-4, interleukin-5, interleukin-13 | Eosinophils, mast cells, IgE class switching | Helminth infection, allergy, asthma |
| Th17 | ROR-gamma-t | Interleukin-17 (and interleukin-22) | Neutrophils — the mucosal defence against fungi and extracellular bacteria | Mucosal candidiasis, pustular psoriasis; deficient when interleukin-17 pathway is blocked |
| Treg (regulatory) | FoxP3 | Interleukin-10 and transforming growth factor-beta | Suppression of other T cells | Prevents autoimmunity; loss causes IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome |
T follicular helper cells, the fifth and biologically distinct subset, are the T cells that move into the germinal centre and supply CD40 help to B cells. Without them, class switching and affinity maturation fail, so a patient with a Tfh defect has recurrent bacterial infection and cannot make good antibody despite normal B-cell numbers — which is why hyper-IgM syndrome from a CD40L defect looks clinically like an antibody deficiency.
Cytotoxic T-cell killing
A CD8 cytotoxic T cell that recognises its peptide on MHC class I kills by two routes. The primary route is directed secretion: perforin forms a pore in the target membrane and granzymes enter and activate the caspase cascade, producing apoptosis of the target cell. The secondary route exploits a surface molecule: Fas ligand on the T cell engages Fas on the target, triggering the extrinsic apoptotic pathway.
| Mechanism | Molecules | Effect on the target |
|---|---|---|
| Perforin–granzyme exocytosis | Perforin pore and granzyme B entering the cytosol | Caspase-9 and caspase-3 activation, DNA fragmentation, apoptosis — one cell kills in a targeted way without spilling virions into the neighbourhood |
| Fas–FasL | Fas ligand engaging CD95 on the target membrane | Apoptosis through caspase-8 |
| Cytokines | Interferon-gamma and tumour necrosis factor | Inhibition of viral replication and activation of nearby macrophages |
NoteApoptosis rather than lysis is the deliberate choice. Killing by membrane rupture would release intact virions to infect neighbours; apoptosis packages the contents into membrane-bound bodies that a phagocyte removes cleanly. Viruses that block caspase activation — adenovirus and herpesvirus both encode inhibitors — are able to survive for precisely this reason.
Delayed-type hypersensitivity and the granuloma
A person previously infected by Mycobacterium tuberculosis carries CD4 T cells primed against mycobacterial peptides. When purified protein derivative is injected intradermally, dendritic cells present it, the recalled Th1 cells release interferon-gamma, macrophages accumulate and cause a raised induration that must be read at 48–72 hours. Reading it at 24 hours or at one week gives a false answer.
The same machinery generates the granuloma when the antigen cannot be cleared: macrophages activated and transformed into epithelioid cells fuse into Langhans giant cells, surrounded by a rim of lymphocytes, with caseous necrosis inside in tuberculosis. The granuloma is a strategy of containment, and it explains why typhoid, sarcoid, tuberculosis and foreign-body reactions all share the word 'granuloma' despite very different causes.
| Setting | Cell-mediated event | Clinical readout |
|---|---|---|
| Tuberculin test (PPD) | Recall of mycobacterial peptide-specific Th1 cells | Induration read at 48–72 hours; positive in latent tuberculosis but also in BCG-vaccinated and non-tuberculous mycobacteria contacts |
| Contact dermatitis | Hapten-specific CD4 and CD8 T cells in skin | Poison ivy and nickel dermatitis, peaking at 48–72 hours |
| Tuberculous pleural effusion | Pleural CD4 recruitment and interferon-gamma | A lymphocytic pleural fluid with high adenosine deaminase |
| Leprosy | Th1 or Th2 dominance along the disease spectrum | Tuberculoid leprosy (Th1, few bacilli, granulomas) versus lepromatous leprosy (Th2, many bacilli, no efficient granulomas) |
Clinical consequences of a failing cell-mediated arm
| Condition | Mechanism | Infection pattern seen |
|---|---|---|
| HIV with a CD4 count falling below 200 | Progressive loss of CD4 T cells by productive infection and apoptosis | Pneumocystis pneumonia, cryptococcal meningitis, oesophageal candidiasis, toxoplasmosis, cytomegalovirus retinitis, disseminated mycobacterial disease |
| DiGeorge syndrome | 22q11.2 deletion, thymic hypoplasia — impaired T-cell development | Recurrent viral and fungal infection, plus hypocalcaemic tetany and a cardiac murmur from conotruncal defect |
| Chronic granulomatous disease | Defective NADPH oxidase, so macrophages cannot kill the organisms they have engulfed | Catalase-positive infections and granulomas — the T cells are intact, the macrophages are not |
| Mendelian susceptibility to mycobacteria | Defects in interferon-gamma and interleukin-12 signalling | Disseminated BCG and environmental mycobacteria |
| Drug-induced immunosuppression | Calcineurin inhibitors, corticosteroids, antiproliferative agents | Cytomegalovirus, BK polyomavirus, fungal infection — a dose-dependent erosion of cell-mediated response |
NoteSevere combined immunodeficiency is the archetype of total failure. It arises from defects of the shared cytokine receptor chain (X-linked SCID), adenosine deaminase deficiency, or RAG defects that abolish receptor rearrangement altogether, and it presents in the first months of life with failure to thrive, oral candidiasis and Pneumocystis, with low lymphocytes and absent thymic shadow. Live vaccines are contraindicated and the treatment is haematopoietic stem-cell transplantation or gene therapy.
Common mistakes
Watch outThinking CD8 T cells need help from CD4 to kill. They need help to be primed — CD4 T cells license the dendritic cell — but once a cytotoxic cell exists, it kills a presenting target cell directly, without any CD4 involvement.
Watch outReading a tuberculin test before 48 hours or at seven days. The reaction is a delayed-type hypersensitivity and matures at 48–72 hours; a reading at 24 hours may be an immediate pseudo-reaction, and a reading after a week may be an immune complex reaction from prior sensitisation.
Watch outCalling type IV hypersensitivity 'delayed' because it is slow in starting and slow in stopping. It is slow in starting — the cells must be recruited from blood — and the readout is measured in days, whereas type I reactions are measured in minutes to hours and type III in hours to days.
Check your understanding
A patient with AIDS has a CD4 count of 120 cells per microlitre and then develops Pneumocystis pneumonia. What is the mechanistic relationship?
Why does an intranasal herpes simplex infection resolve through cell-mediated rather than humoral immunity?
A patient with a CD40 ligand deficiency has normal B-cell numbers but only IgM, and recurrent bacterial infection. Explain.
Multiple choice
Which statement about MHC presentation is correct?
A kidney transplant recipient on cyclosporine develops fever, malaise and a rising plasma cytomegalovirus load. Which alteration in immune function does this illustrate?
A 25-year-old with a positive interferon-gamma release assay and no symptoms has a normal chest radiograph. What does this pattern imply?
Summary and next
Cell-mediated adaptive immunity is the intracellular arm. Endogenous proteins are presented on MHC class I to CD8 cytotoxic T cells, which kill by perforin–granzyme apoptosis; exogenous proteins are presented on MHC class II to CD4 T cells, which differentiate into Th1, Th2, Th17, Tfh or regulatory lineages depending on the cytokine signal. Activation needs a second signal — B7 engaging CD28 — and its absence produces anergy. The same machinery, when it targets an organism that cannot be cleared, drives delayed-type hypersensitivity and the granuloma, which is why the tuberculin test is read at 48 to 72 hours and why a falling CD4 count converts Pneumocystis from commensal to pathogen.
Next: antigen–antibody reactions. You will take the specificity and affinity you have met here into the diagnostic laboratory, and see how precipitation, agglutination, ELISA and immunofluorescence turn an antibody response into a number on a report.